logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 3
  • 1
    Taslaq, Samer, Dr
    Director born in May 1980
    Individual (24 offsprings)
    Officer
    2017-07-03 ~ 2020-02-14
    OF - Director → CIF 0
    Dr Samer Taslaq
    Born in May 1980
    Individual (24 offsprings)
    Person with significant control
    2017-07-17 ~ 2025-08-18
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Watson, Paul
    Born in May 1972
    Individual (11 offsprings)
    Officer
    2016-12-05 ~ now
    OF - Director → CIF 0
    Mr Paul Watson
    Born in May 1972
    Individual (11 offsprings)
    Person with significant control
    2016-12-05 ~ 2025-08-18
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
  • 3
    NORTHUMBRIA PHARMA GROUP HOLDINGS LTD
    16171886
    Netpark, Thomas Wright Way, Sedgefield, County Durham, England
    Active Corporate (2 parents, 3 offsprings)
    Person with significant control
    2025-08-18 ~ now
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Ownership of shares – 75% or more → CIF 0
parent relation
Company in focus

NORTHUMBRIA PHARMA LTD

Period: 2016-12-05 ~ now
Company number: 10509764
Registered name
NORTHUMBRIA PHARMA LTD - now
Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Distribution Costs
-16,982 GBP2024-05-01 ~ 2025-04-30
-5,666 GBP2023-05-01 ~ 2024-04-30
Administrative Expenses
-2,575,931 GBP2024-05-01 ~ 2025-04-30
-2,322,362 GBP2023-05-01 ~ 2024-04-30
Other Interest Receivable/Similar Income (Finance Income)
36,326 GBP2024-05-01 ~ 2025-04-30
30,215 GBP2023-05-01 ~ 2024-04-30
Profit/Loss on Ordinary Activities Before Tax
-29,504 GBP2024-05-01 ~ 2025-04-30
157,203 GBP2023-05-01 ~ 2024-04-30
Profit/Loss
10,629 GBP2024-05-01 ~ 2025-04-30
115,235 GBP2023-05-01 ~ 2024-04-30
Comprehensive Income/Expense
10,629 GBP2024-05-01 ~ 2025-04-30
115,235 GBP2023-05-01 ~ 2024-04-30
Intangible Assets
Other than goodwill
588,083 GBP2025-04-30
676,491 GBP2024-04-30
Property, Plant & Equipment
577,775 GBP2025-04-30
636,976 GBP2024-04-30
Fixed Assets
1,165,858 GBP2025-04-30
1,313,467 GBP2024-04-30
Debtors
21,617,650 GBP2025-04-30
1,528,903 GBP2024-04-30
Cash at bank and in hand
5,330,325 GBP2025-04-30
1,212,351 GBP2024-04-30
Current Assets
38,173,104 GBP2025-04-30
4,661,074 GBP2024-04-30
Creditors
Amounts falling due within one year
-37,056,400 GBP2025-04-30
-3,476,949 GBP2024-04-30
Net Current Assets/Liabilities
1,116,704 GBP2025-04-30
1,184,125 GBP2024-04-30
Total Assets Less Current Liabilities
2,282,562 GBP2025-04-30
2,497,592 GBP2024-04-30
Creditors
Amounts falling due after one year
-455,557 GBP2025-04-30
-632,215 GBP2024-04-30
Net Assets/Liabilities
1,720,343 GBP2025-04-30
1,709,714 GBP2024-04-30
Equity
Called up share capital
48,000 GBP2025-04-30
48,000 GBP2024-04-30
48,000 GBP2023-04-30
Retained earnings (accumulated losses)
1,672,343 GBP2025-04-30
1,661,714 GBP2024-04-30
1,546,479 GBP2023-04-30
Equity
1,720,343 GBP2025-04-30
1,709,714 GBP2024-04-30
Profit/Loss
Retained earnings (accumulated losses)
10,629 GBP2024-05-01 ~ 2025-04-30
115,235 GBP2023-05-01 ~ 2024-04-30
Audit Fees/Expenses
30,300 GBP2024-05-01 ~ 2025-04-30
30,750 GBP2023-05-01 ~ 2024-04-30
Average Number of Employees
292024-05-01 ~ 2025-04-30
282023-05-01 ~ 2024-04-30
Wages/Salaries
1,189,960 GBP2024-05-01 ~ 2025-04-30
1,148,431 GBP2023-05-01 ~ 2024-04-30
Pension & Other Post-employment Benefit Costs/Other Pension Costs
223,730 GBP2024-05-01 ~ 2025-04-30
23,415 GBP2023-05-01 ~ 2024-04-30
Staff Costs/Employee Benefits Expense
1,532,538 GBP2024-05-01 ~ 2025-04-30
1,295,329 GBP2023-05-01 ~ 2024-04-30
Director Remuneration
80,034 GBP2024-05-01 ~ 2025-04-30
147,473 GBP2023-05-01 ~ 2024-04-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-49,001 GBP2024-05-01 ~ 2025-04-30
-18,152 GBP2023-05-01 ~ 2024-04-30
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
884,103 GBP2024-04-30
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
296,020 GBP2025-04-30
207,612 GBP2024-04-30
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
88,408 GBP2024-05-01 ~ 2025-04-30
Intangible Assets
Patents/Trademarks/Licences/Concessions
588,083 GBP2025-04-30
676,491 GBP2024-04-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
969,683 GBP2025-04-30
967,037 GBP2024-04-30
Computers
82,554 GBP2025-04-30
75,885 GBP2024-04-30
Motor vehicles
27,729 GBP2025-04-30
27,729 GBP2024-04-30
Property, Plant & Equipment - Gross Cost
1,079,966 GBP2025-04-30
1,070,651 GBP2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
448,404 GBP2025-04-30
390,529 GBP2024-04-30
Computers
41,775 GBP2025-04-30
33,907 GBP2024-04-30
Motor vehicles
12,012 GBP2025-04-30
9,239 GBP2024-04-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
502,191 GBP2025-04-30
433,675 GBP2024-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
57,875 GBP2024-05-01 ~ 2025-04-30
Computers
7,868 GBP2024-05-01 ~ 2025-04-30
Motor vehicles
2,773 GBP2024-05-01 ~ 2025-04-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
68,516 GBP2024-05-01 ~ 2025-04-30
Property, Plant & Equipment
Plant and equipment
521,279 GBP2025-04-30
576,508 GBP2024-04-30
Computers
40,779 GBP2025-04-30
41,978 GBP2024-04-30
Motor vehicles
15,717 GBP2025-04-30
18,490 GBP2024-04-30
Finished Goods/Goods for Resale
11,225,129 GBP2025-04-30
1,919,820 GBP2024-04-30
Trade Debtors/Trade Receivables
Current
19,405,022 GBP2025-04-30
1,466,585 GBP2024-04-30
Amount of corporation tax that is recoverable
Current
6,130 GBP2025-04-30
0 GBP2024-04-30
Other Debtors
Current
6,992 GBP2025-04-30
7,342 GBP2024-04-30
Prepayments/Accrued Income
Current
2,199,506 GBP2025-04-30
54,976 GBP2024-04-30
Bank Borrowings/Overdrafts
Current
160,707 GBP2025-04-30
165,730 GBP2024-04-30
Trade Creditors/Trade Payables
Current
30,258,925 GBP2025-04-30
1,284,350 GBP2024-04-30
Corporation Tax Payable
Current
0 GBP2025-04-30
60,120 GBP2024-04-30
Other Taxation & Social Security Payable
Current
3,329,422 GBP2025-04-30
424,837 GBP2024-04-30
Other Creditors
Current
9,612 GBP2025-04-30
11,390 GBP2024-04-30
Accrued Liabilities/Deferred Income
Current
2,294,495 GBP2025-04-30
223,768 GBP2024-04-30
Creditors
Current
37,056,400 GBP2025-04-30
3,476,949 GBP2024-04-30
Bank Borrowings/Overdrafts
Non-current
455,557 GBP2025-04-30
632,215 GBP2024-04-30
Bank Borrowings
616,264 GBP2025-04-30
797,945 GBP2024-04-30
Total Borrowings
Current
160,707 GBP2025-04-30
165,730 GBP2024-04-30
Non-current
455,557 GBP2025-04-30
632,215 GBP2024-04-30
Par Value of Share
Class 1 ordinary share
1 GBP2024-05-01 ~ 2025-04-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
48,000 shares2025-04-30
48,000 shares2024-04-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
73,683 GBP2025-04-30
57,605 GBP2024-04-30
Between two and five year
211,193 GBP2025-04-30
224,576 GBP2024-04-30
More than five year
0 GBP2025-04-30
42,762 GBP2024-04-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
284,876 GBP2025-04-30
324,943 GBP2024-04-30
  • NORTHUMBRIA PHARMA LTD
    Info
    Registered number 10509764
    Netpark, Thomas Wright Way, Sedgefield, County Durham TS21 3FD
    PRIVATE LIMITED COMPANY incorporated on 2016-12-05 (9 years 5 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-08-18
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.